Imaging for early stage breast cancer

Overview

• The natural history of ”low risk” breast cancer • Caution about fractionation – Fractionation theories – Experience from Norway and Sweden • Preliminary results – Problems reported from the RAPID trial – Problems reported from the ELIOT trial – Problems reported from the TARGIT trial • Non-scientific reasons for use of APBI